Meyka Pro banner
Avantor, Inc.

Avantor, Inc. (AVTR) Stock Overview

Explore Avantor, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AVTRNYSE
HealthcareMedical - Instruments & Supplies
$14.25
$0.29(2.08%)
U.S. Market opens in 15h 41m

Avantor, Inc. (AVTR)

Meyka AI Score

Z

Key Financials

Market Cap9.6B
P/E Ratio-16.64
EPS (TTM)$0.85
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 Month$13.09
3 Months$13.27
1 Year Target$6.48

AVTR Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Avantor, Inc. (NYSE: AVTR) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Avantor, Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AVTR on the NYSE shows an RSI of 68.60, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $6.48 for the NYSE listing.

Key metrics behind Avantor, Inc.'s NYSE-traded stock include a P/E ratio of -16.64 and a market capitalization of 9.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AVTR on the NYSE.

Price Performance (NYSE: AVTR)

1-Day Change
2.08%
5-Day Change
3.41%
1-Month Change
33.68%
3-Month Change
80.84%
6-Month Change
57.81%
Year-to-Date (YTD) Change
24.35%
1-Year Change
10.64%
3-Year Change
-35.14%
5-Year Change
-63.20%
All-Time (Max) Change
-1.72%

Contact Information

610 386 1700
Radnor Corporate Center, Radnor, PA, 19087

Company Facts

135,000 Employees
IPO DateMay 17, 2019
CountryUS
Actively Trading

Frequently Asked Questions